A total of @ Chinese patients with AICAS were enrolled and randomly divided into three groups -LSB- low-dose atorvastatin therapy ( LAT , @mg/day ) , standard-dose atorvastatin therapy ( SAT , @mg/day ) , and intensive-dose atorvastatin therapy ( IAT , @mg/day ) groups -RSB- in a @:@:@ ratio .